Obesity Rate Stalls in Wegovy-Maker Novo’s Home Market

Novo launched Wegovy in Denmark at the end of 2022.

Photographer: Shelby Knowles/Bloomberg

Obesity levels have plateaued after years of increases in the home of weight-loss pioneer Novo Nordisk A/S.

The share of Danish adults and older teenagers living with obesity was 18.5% in 2025, unchanged from 2021, according to a new national survey released Thursday. That follows years of increases from a 13.6% rate in 2010.